Answers are grounded in this paper and cite their sources.
Study proves the connection between Universal Generative Principle and Standard Model interactions, suggesting fundamental stability of proton decay.
We prove in Lean 4, with zero \ for all theorem-grade claims, that the Universal Generative Principle (UGP) winding, chirality, hypercharge, and color-fiber data determine the Standard Model's finite renormalizable interaction skeleton: gauge-fermion vertices, Yukawa mass-generating vertices, anomaly cancellation, representation-level color-singlet constraints, proton-stability forbiddance at dimension four, and a topological dark-sector isolation gap. The winding number W = N_cQ, the GTE chirality fiber T/T^, integerized hypercharge Y_3 = 2W - T_6 = 3Y (e.g., Y_3(e_L) = -3, Y_3(Q_L) = +1, Y_3(e_R) = -6, Y_3(u_R) = +4), and the minimal gauge-boson winding spectrum \0, 3\ suffice to reproduce all renormalizable SM vertex schemas and exclude all forbidden ones-without any additional gauge-theoretic input. The main theorem-UGPVertex(f_1,f_2,B) SMVertex(f_1,f_2,B) for all colored fermions f_1,f_2 and gauge bosons B-is proved by exhaustive finite case analysis. A vertex audit over 64 electroweak schemas returns MISMATCH COUNT\,=\,0 (SHA-256: c927758a9b7801db). Three independent proofs force N_c = 3; the SM fermion quartet is the unique anomaly-free solution at N_c = 3; proton decay at dimension four is topologically forbidden; and fermions with W \1,-2,4\ are isolated from all SM particles via SM bosons. Electroweak predictions from Lean-certified bare couplings give m_W = 80.364\,GeV (-0.42 vs PDG 2024 world average 80.3692 0.0133) and _s(M_Z) = 0.1179 (0.0). These results were independently foreshadowed computationally: the PR-1/Logos cellular automaton recovered the winding-transfer structure at 87.38\% consistency with zero false negatives over 1.02 10^6 events, and the PR-0/MFRR field substrate exhibited force emergence from dissonance minimization, both before the Lean proofs were written.
No takes yet. Share an insight, caveat, or question.
Nova Spivack (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: